Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.


ASH 2018: ECHELON-2 trial

Prof. Lorenz Trümper about the ECHELON-2 trial.

  • Sponsors

    This program is editorially independent and is financially made possible by

Related items

Congresnieuws 11/12/2018

ASH 2018: Highlights lymphoma

Dr. Martin Hutchings from Denmark talks about the first in-human trial he presented at ASH 2018 and mentions another congress highlight: the ECHELON-2 trial.

Congresnieuws 11/12/2018

ASH 2018: ACT 1-2

Presenter Francesco d'Amore summarizes the final results of the ACT-1/2 trial.

Congresnieuws 14/12/2012

ASH 2012 | Hematology News Program 3

Third Hematology TV News Program from the ASH 2012 TPA-agonist romiplostim: can we reconsider its use in MDS? Have we arrived into the era of targeted therapy in CLL with ibrutinib? JAK-inhibition may be relevant for MPN beyond myelofibrosis

Congresnieuws 16/06/2012

EHA 2012 | News Program 16/06/12

EHA 2012 Hematology TV News Program June 16 Myelodysplastic Syndromes Interview Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia Non-Hodgkin Lymphoma

Congresnieuws 16/06/2012

EHA 2012 | News Program June 16

EHA 2012 Hematology TV News Program June 16. Myelodysplastic Syndromes Interview Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia Non-Hodgkin Lymphoma